drugset / Trial / NCT04118296

Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream

NCT04118296

Phase 1/2 Completed 150 enrolled Sukma Skin Treatment
NaSingle-groupOpen-labelTreatment

Summary

This study was conducted to see whether there was a decrease in the degree of acne vulgaris / pimple, to find out what proportion of respondents experienced a decrease in severity and who did not experience a decrease in the severity of acne vulgaris after the use of an anti-acne cream combination containing active ingredients such as; Tretinoin 0.05% (derivatives of Vitamin A), Clindamycin 5% (antibiotics), and Dexamethasone 0.05% (anti-inflammatory) for 1 month of use.

Timeline

Start
2019-10-08
Primary completion
2019-11-06
Completion
2019-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Clindamycin Unknown 3 % Topical
Subject Dexamethasone Small molecule 0.05 % Topical
Subject Tretinoin Small molecule 0.05 % Topical

Indications